Addiction Medicine Updates
Latest News & Upcoming Events
On December 26, the American Society of Addiction Medicine (ASAM) submitted comments on amendments to regulations under the Federal anti-kickback statute (AKS), which would modify and add new safe harbors under the statute, as well as make changes to encourage...
On January 2, the Food and Drug Administration released its industry guidance regarding its enforcement priorities for electronic nicotine delivery systems (ENDS). Notably, the guidance indicates that it will pursue action to clear the market of all flavored...
Association Between Methamphetamine Use and Retention Among Patients with Opioid Use Disorders Treated with Buprenorphine
Methamphetamine use is increasing in parts of the U.S., yet its impact on treatment for opioid use disorder is relatively unknown. This study found that patients who concurrently used methamphetamine were less likely to be retained in buprenorphine treatment compared...
This training will provide four of the required hours for doctors, nurse practitioners, and physician assistants to apply for a waiver to prescribe buprenorphine, one of the FDA approved medications to treat opioid use disorder (OUD). It will be an opportunity to learn more about MAT, OUD, the waiver process, and how MAT can work in a primary care practice.